Limits...
3-Methyl-1,4-dioxo-1,4-dihydro-naphthalen-2-yl 4-amino-benzoate.

Bambagiotti-Alberti M, Bartolucci G, Bruni B, Coran S, Di Vaira M - Acta Crystallogr Sect E Struct Rep Online (2008)

Bottom Line: The crystal structure of the title compound, C(18)H(13)NO(4), the oxidized form of the drug aminaftone used in venous disease therapy, is characterized by the presence of ribbons of hydrogen-bonded mol-ecules parallel to the [111] crystallographic direction and by stacking inter-actions between rings [centroid-centroid distance between quinone rings = 3.684 (3) Å and between amino-benzoate rings = 4.157 (3) Å] along the ribbons.

View Article: PubMed Central - HTML - PubMed

ABSTRACT
The crystal structure of the title compound, C(18)H(13)NO(4), the oxidized form of the drug aminaftone used in venous disease therapy, is characterized by the presence of ribbons of hydrogen-bonded mol-ecules parallel to the [111] crystallographic direction and by stacking inter-actions between rings [centroid-centroid distance between quinone rings = 3.684 (3) Å and between amino-benzoate rings = 4.157 (3) Å] along the ribbons.

No MeSH data available.


Related in: MedlinePlus

A view of the crystal packing in the structure of I, showing the presence of ribbons formed by H–bonded molecules. H–bonds are denoted by dashed lines.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC2961024&req=5

Fap2: A view of the crystal packing in the structure of I, showing the presence of ribbons formed by H–bonded molecules. H–bonds are denoted by dashed lines.


3-Methyl-1,4-dioxo-1,4-dihydro-naphthalen-2-yl 4-amino-benzoate.

Bambagiotti-Alberti M, Bartolucci G, Bruni B, Coran S, Di Vaira M - Acta Crystallogr Sect E Struct Rep Online (2008)

A view of the crystal packing in the structure of I, showing the presence of ribbons formed by H–bonded molecules. H–bonds are denoted by dashed lines.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC2961024&req=5

Fap2: A view of the crystal packing in the structure of I, showing the presence of ribbons formed by H–bonded molecules. H–bonds are denoted by dashed lines.
Bottom Line: The crystal structure of the title compound, C(18)H(13)NO(4), the oxidized form of the drug aminaftone used in venous disease therapy, is characterized by the presence of ribbons of hydrogen-bonded mol-ecules parallel to the [111] crystallographic direction and by stacking inter-actions between rings [centroid-centroid distance between quinone rings = 3.684 (3) Å and between amino-benzoate rings = 4.157 (3) Å] along the ribbons.

View Article: PubMed Central - HTML - PubMed

ABSTRACT
The crystal structure of the title compound, C(18)H(13)NO(4), the oxidized form of the drug aminaftone used in venous disease therapy, is characterized by the presence of ribbons of hydrogen-bonded mol-ecules parallel to the [111] crystallographic direction and by stacking inter-actions between rings [centroid-centroid distance between quinone rings = 3.684 (3) Å and between amino-benzoate rings = 4.157 (3) Å] along the ribbons.

No MeSH data available.


Related in: MedlinePlus